Dr. Kopach is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
670 Albany St Ste 304
Boston, MA 02118Phone+1 617-414-4291Fax+1 617-414-5315
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Genitourinary Pathology, 2019 - 2020
- Memorial Sloan Kettering Cancer CenterFellowship, Oncologic Pathology, 2018 - 2019
- Tufts Medical CenterResidency, Pathology-Anatomic and Clinical, 2014 - 2018
- Belarusian State Medical University Class of 2007, MD
Certifications & Licensure
- MA State Medical License 2014 - 2026
- TX State Medical License 2020 - 2025
- MA State Medical License 2021 - 2024
- NY State Medical License 2018 - 2020
- PA State Medical License 2017 - 2018
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- 92 citationsInterleukin-33 potentiates bleomycin-induced lung injury.Irina G. Luzina, Pavel Kopach, Virginia Lockatell, Phillip H. Kang, Ashish Nagarsekar
American Journal of Respiratory Cell and Molecular Biology. 2013-12-01 - 9 citationsAberrant integrin αv and α5 expression in prostate adenocarcinomas and bone-metastases is consistent with a bone-colonizing phenotypeBrendan Connell, Pavel Kopach, Wenying Ren, Raghav Joshi, Stephen P. Naber
Translational Andrology and Urology. 2020-07-22 - 89 citationsFull-Length IL-33 Promotes Inflammation but not Th2 Response In Vivo in an ST2-Independent FashionIrina G. Luzina, Edward M. Pickering, Pavel Kopach, Phillip H. Kang, Virginia Lockatell
Journal of Immunology. 2012-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: